Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting 121
Tuesday, November 6, 2018, 8:47 a.m. to 10:09 a.m.
Bill Casey, Chair (Liberal)

• Julie Dabrusin for Sonia Sidhu (Liberal)
• Tom Kmiec for Len Webber (Conservative)
Library of Parliament
• Nadia Faucher, Analyst
• Karin Phillips, Analyst
Patented Medicine Prices Review Board
• Douglas Clark, Executive Director
Canadian Agency for Drugs and Technologies in Health
• Heather Logan, Acting Vice-President, Pharmaceutical Reviews
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Wednesday, April 18, 2018, the Committee resumed its study on barriers to access to treatment and drugs for Canadians affected by rare diseases and disorders.

The witnesses made statements and answered questions.

At 10:07, by unanimous consent and pursuant to Standing Order 115(5), it was agreed that the Committee continue to sit.

At 10:09 a.m., the Committee adjourned to the call of the Chair.

Marie-Hélène Sauvé
Clerk of the Committee